Cervical cancer: What the international study shows for Greece
Published
A new international study examines cervical cancer and its relationship with Greece. The material available to us contained only the title of the study, so this article presents general information on the topic and does not report specific findings.
Cervical cancer usually develops after infection with the human papillomavirus (HPV). This virus is very widespread and is transmitted mainly through sexual contact. Often the infection causes no symptoms and passes without being noticed.
The main preventive measures are HPV vaccination and regular screening. Screening includes the Pap test and the HPV test, which can detect changes in cells before they develop into cancer. Doctors stress that early detection significantly increases the chances of successful treatment.
Experts often point out that proper information for women and young people about vaccination and screening is very important. To fully understand the study's results and the data for Greece, the full version of the research is needed. Anyone with questions about vaccination or screening can consult their family doctor or their gynaecologist.
Sources: Healthpharma
More Greece news
- The electric Renault 5 gains greater range and arrives in Greece with a special Roland-Garros edition
- Greece to contribute €120 million to European fund for high-tech companies
- Decline in technology and artificial intelligence stocks: How exposed are Greek companies?
- Meeting of Fidan and Güler on the cable across three capitals
- Interview Poll: New Democracy First with 29.4%, Ten Parties in Parliament
- Greece-Cyprus Cable: What Hatzidakis Said About France's License
- Conference on Access to Healthcare: Stelios Kymbouropoulos on the Today Press panel
- Georgia Parasxou at the Health Access Greece conference